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It is only recently that  rheumatoid  factor (RF)i-like  anti-IgG autoantibodies  have 
been studied in the mouse. They were first detected in high titers in the mutant strain 
MRL/I,  which  develops  a  severe  autoimmune  disease  characterized  by  massive  T 
lymphocyte proliferation  and  autoantibody  production  against  many different  self- 
antigens  (1).  Soon thereafter  the presence of RF was also recognized in the serum of 
many normal strains from various colonies (2,  3).  In most of these strains, the titers of 
RF increase  with  age and  in some, like the  129/Sv,  they reach levels comparable to 
those  of the  MRL/I.  In addition  to  these  RF  of spontaneous  origin,  RF  were  also 
detected  in the serum  of several  normal  mouse strains  after injection of lipopolysac- 
charide  (LPS)  (4).  This polyclonat activator of B tymphocytes proved to be a  potent 
stimulus for the induction of RF: it was found by plaque-forming cell techniques that 
a  high  proportion  of the  B  lymphocytes  stinmlated  to  IgM  production  by  LPS 
produce  IgM with  RF  activity  (5,  6,  7).  In addition,  the  hybridomas  derived  from 
spleen  cells  polyclonally  activated  in  vivo  frequently  secreted  IgM  with  anti-IgG 
activity (8). 
The  specificity  of mouse  RF  has  mainly  been  studied  in  the  129/Sv strain.  The 
autoantibodies spontaneously produced by these mice in certain colonies preferentially 
reacted  with  IgG2a (2).  In contrast,  the monoclonal RF derived  from  129/Sv spleen 
cells after polyclonal activation  in vivo had a  very different spectrum of specificities, 
since  most  were  specific  for  IgG1.  It  thus  seemed  that,  in  this  strain,  RF  may  be 
selectively activated  in vivo on the basis of their subclass specificity.  It was therefore 
of interest  to find out  whether subclass  specificity is a  peculiarity  of certain  129/Sv 
RF or is  a  fundamental  characteristic  of all  mouse  RF.  Accordingly, we  tested  the 
specificity of RF found in the serum of various mouse strains  including autoimmune 
strains like NZB and MRL/I. We also examined the specificity of RF secreted in vitro 
by spleen cells of several strains upon stimulation with LPS. In addition, we generated 
a  large  number  of monoclonal  RF  from  four  different  strains  under  a  variety  of 
conditions including polyclonal activation in vitro. The results indicate that whatever 
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the strain or mode of induction, all the mouse  RF that  were analyzed reacted with 
subclass-specific structures. 
Materials  and  Methods 
Mice.  129/Sv,  C57B1/6,  BALB/c,  and  CBA/Ht  mice  were  maintained  under  specific 
pathogen-free conditions in the colony of our Institute by Dr. Guy Warnier. The  first three 
strains were derived from breeders given by Dr. J. L. Gu~net, Institut Pasteur, Paris, the last 
from breeders obtained from Dr. H. Hewitt. NZB/Binj, MRL/I, RIIIS/J, and CE/J mice were 
obtained from The Jackson Laboratory, Bar Harbor, ME, and A/HeJ from the Central Animal 
Laboratory, University of Nijmegen, The Netherlands. 
Polyclonal Stimulation In  Vitro.  Spleen cells were teased in  Hanks' balanced salts solution 
containing 5% fetal bovine serum (FBS). Cell suspensions were filtered through a nylon mesh 
gauze  (80  /~m; Nylon  Swiss;  J.  Staniar  and  Co.,  Manchester,  United  Kingdom  [UK]), 
centrifuged at  100 g  for  10  min  and  resuspended  at  5  ×  l0  S cells/ml  in  Iscove's medium 
supplemented with  5%  FBS,  1-glutamine (1.5  ×  10 -3 M),  1-asparagine  (2.4  ×  10  -4 M),  1- 
arginine (5.5  ×  10  -4 M),  2-mercaptoethanol  (5  ×  10  -~ M), and  either 25  /lg/ml LPS  from 
Escherichia coh  (055:B5;  Difco Laboratories, Detroit, MI)  or 25  /~g/ml  LPS  plus 200 /~g/ml 
dextran sulfate (DS) (500,000  mol wt; Pharmacia Fine Chemicals, Uppsala, Sweden). 
Cell Fusion and Culture.  Polyclonally activated or untreated normal spleen cells were fused 
with SP2/0-Ag-14 myeloma cells at a  5:1  ratio according to the method described previously 
(8). The myeloma cells were grown in Iscove's medium enriched with 10% FBS. 
Coupling of Proteins to Polystyrene Particles.  Proteins were coupled to carboxylated polystyrene 
particles, 0.8/~m,  (Rh~ne-Poulenc, Courbevoie, France) after activation of the latter with  1- 
ethyl-3(3-dimethyl-aminopropyl)-carbodiimide  as described by Masson et al. (9).  Briefly, 250 
/~g of protein was  added  to  50 /~1  of a  10%  (vol/vol) suspension  of carbodiimide-activated 
particles.  After overnight  incubation  at  4°C  and  appropriate washing  the  particles were 
resuspended in  1 ml of glycine-buffered saline (GBS)  (0.1 M  glycine, 0.15  M  NaCI, pH 9.2) 
containing 1% bovine serum albumin (BSA). Before use, these suspensions were further diluted 
10 times in the same buffer and sonicated at 25 W for 15 s (Branson Sonic Power Co., Danbury, 
CT). By this method, the number of molecules coupled per particle was, respectively, 10-15,000 
for human IgG and mouse IgG1, IgG2a, and IgG2b; 3,000 for mouse IgM; 7,000 for ovalbumin; 
and 25,000  for lysozyme. 
Detection of RF-secreting Clones.  The  large  numbers  of clones generated  by  the  fusion  of 
polyclonally activated spleen cells were screened for antibody activity by testing the ability of 
their  secretion  products  to  agglutinate  polystyrene particles coated  with  various  proteins. 
Aliquots (20/~1) of medium were mixed with an equal volume of particles in round-bottomed 
microtiter plates (Greiner, Nurtingen, Federal Republic of Germany [FRG]). By this system 
agglutinations were readily screened visually after 2 h of incubation at room temperature (Fig. 
1). The limit of IgM antibody detection by this assay was =0.1/Lg/ml. 
Inhibition of  Agglutination with Heat-aggregatedIgG.  RF preparations were incubated for 1 h at 
37°C with heat-aggregated IgG before addition of the IgG-coated particles. After 1 h more at 
37°C, the inhibition of agglutination was measured by counting the number of nonagglutinated 
particles with a particl  e counter as described previously (2). 
Radioimmunoassays.  Polyvinyl flexible microtiter plates (Flow Laboratories, Inc., Rockville, 
MD)  were coated by ove/'n~ght  incubation with  25 /~1 of a  10 p.g/ml protein solution in  1:5 
diluted GBS. After washing in saline containing 0.01% Tween 20 (Technicon Chemicals, Orcq, 
Belgium), they were incubated for 3 h  at 37°C with monoclonal RF. Nonspecific binding was 
drastically reduced  by subsequently soaking  the  plates  for  7  rain  in  saline containing  1% 
Nonidet P-40  (Fluka AG, Buchs, Switzerland), before further incubation  (2 h  at 37°C)  with 
125I-labeled affinity-purified goat antibodies specific for mouse IgM. 
Protein Preparations.  Monoclonal  and  polyclonal mouse  IgG  subclasses were  purified  by 
sequential elution from protein A-Sepharose as described (10).  Monoclonal IgM was isolated 
from ascitic fluid by ammonium sulfate precipitation, gel filtration on AcA22 Ultrogel (LKB 
Produkter, Bromma, Sweden), and preparative Pevikon-block electrophoresis (SERVA Fein- 
biochemica GmbH  & Co., Heidelberg, FRG). Mouse transferrin was purified by chromatog- 
raphy on  DEAE-cellulose (D32;  Whatman  Ltd., Kent,  UK), and  get  filtration on  Ultrogel 1008  SPECIFICITY  OF  MOUSE  RHEUMATOID FACTORS 
FIG.  1.  Agglutination of IgGl-eoated  polystyrene particles in microtiter plates. Culture  medium 
from an RF-secreting hybridoma (left well) and control medium (right well) were incubated far 2 
h with a 1% suspension of polystyrene particles coated with IgG1. 
AcA44.  Human  IgG  was  isolated  from  a  pool  of  human  serum  by  ammonium  sulfate 
precipitation and chromatography on DEAE-cellulose, Hen egg white lysozyme was purchased 
from Koch-Light Laboratories Ltd., Berkshire,  U.K.,  and ovalbumin  from Sigma Chemical 
Co., St.  Louis, MO. 
Results 
Subclass Specificity  of Polyclonal RF of Spontaneous Origin.  RF are regularly found in 
the serum  of various normal and autoimmune strains  of mice. We tested by compe- 
tition experiments  the specificity of the RF of two strains with autoimmune diseases 
(MRL/1 and NZB/BinJ)  and of three "normal" strains (C57B1/6, CBA/Ht, and  129/ 
Sv)  whose sera were  found to strongly agglutinate  polystyrene particles  coated with 
either IgG1 or IgG2a. 
Addition of graded  quantities  of heat-aggregated  IgG1  or IgG2a to  these  diluted 
sera  resulted  in a  complete inhibition  of the agglutination when the competing IgG 
and the IgG on the particles had the same isotype. No inhibition was observed when 
the subclass of the inhibiting IgG differed from that of the IgG present on the particles 
(Table  I).  These  anti-IgG1  and  anti-IgG2a  autoantibodies  therefore  belonged  to 
distinct  antibody  populations.  Unlike  the  sera  of the  three  normal  strains,  those  of 
MRL/I  and  NZB/BinJ  mice  also  agglutinated  particles  coated  with  IgG2b.  The 
latter  agglutination  was again subclass specific since it was inhibited  by heat-aggre- 
gated IgG2b but not by IgG1 or IgG2a (Fig. 2). 
Subclass Specificity  of Polyclonal RF Induced by In  Vitro Stimulation  with  LPS.  Spleen 
cells of 129/Sv and C57B1/6 mice were stimulated in vitro with LPS and the secreted 
anti-lgG autoantibodies  were analyzed for subclass specificity by competition exper- VAN  SNICK,  STASSIN,  AND  DE  LESTRE 
TABLE  I 
Specificity of Polyclonal Mouse RF of Spontaneous Origin 
1009 
Particles coated 
with 
Serum  Control ag-  Strain*  dilution  glutination 
Concentration of heat-aggre- 
gated IgG~ inhibiting aggluti- 
nation by 50% 
IgG1  lgG2a 
IgG 1 
IgG2a 
mg/ml 
C57B1/6  1  : 10  84§  0.003  > 1 
CBA/H t  1  :  2  57  0.050  > 1 
MRL/I  1:30  85  0.016  >1 
NZB/BinJ  1:5  70  0.003  > 1 
129/Sv  1  :  2  76  0.004  > l 
(257B1/6  1:15  85  > 1  0.025 
(2BA/Ht  1:135  78  >1  0.001 
MRL/I  1:135  58  >1  0.017 
NZB/BinJ  1:5  82  > 1  0.009 
129/Sv  1  : 135  76  > 1  0.003 
* For each strain pooled sera from 5 to 10 mice >6 mo old were used.  After appropriate dilution in GBS 
containing 1% BSA and heating at 56°(2 for 30 rain to destroy any thermolabile agglutinators, sera were 
incubated with various concentrations of heat-aggregated  IgG for  1 h  at  37°C.  Polystyrene particles 
coated with IgG1  or IgG2a were then added to the mixture and incubated with shaking at 37°(2 for 1 h. 
Finally, residual nonagglutinated particles were counted instrumentally (2). 
MOPC-31(2 was used as competing IgG1  and MOP(2-173 as competing IgG2a. To ensure the subclass 
specificity of the inhibitions, the polystyrene particles were coated with different monocloual proteins of 
129/Sv origin (108B7 for IgGl and 1103G4 for [gG2a). 
§ Percent agglutinated particles measured in the absence of inhibitor. 
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Fro.  2.  IgG2b-specific RF in MRL/1  and NZB/BinJ mice. Sera of 4-mo-old MRL/I and NZB/ 
BinJ mice diluted  1:5 in GBS were incubated at  37~(2 with heat-aggregated IgGl  (108B7  [I]), 
IgG2a (MOPC-173 [O]), monoclonal IgG2b (307E3  [A]), and polyclonal IgG2b isolated from 129/ 
Sv serum  (F-I). 1 h  later, particles coated with monoclunal IgG2b  (308A8)  were added and the 
agglutinated particles measured after a further 60 min incubation at 37°C. 
iments  similar  to  those  used  for  the  analysis  of RF  found  in  mouse  sera.  With  this 
technique, no cross-reaction could be detected between antibodies reacting with either 
IgG1  or IgG2a  (Table II). 
Similar  experiments  were  carried  out  with  spleen  cells  of A/He J,  CBA/Ht,  and 
RIIIS/J  mice.  The  culture  media  strongly  agglutinated  particles  coated  with  IgG1 
and  to  a  lesser extent  particles  coated  with  IgG2a.  The  latter reaction  however,  was 
too weak to be properly analyzed by competition  experiments. We therefore restricted 
the  specificity  analysis  to  the  agglutination  of  IgG1  particles.  To  ensure  that  low 
affinity  reactions  would  not  be  overlooked,  the  latter  analysis  was  carried  out  by 1010  SPECIFICITY OF  MOUSE  RltEUMATOID FACTORS 
TABLE  lI 
Specificity of Polyclonal RF Induced by In  Vitro Stimulation with LPS 
Strain*  Inhibitor:}: 
Inhibition of the 
agglutination§ of particles 
coated with 
lgOl  IgG2a 
C57Bl/6  IgG1 (108B7)  81  0 
IgG2a (MOPC- 173)  4  78 
129/Sv  lgGl  (108B7)  72  0 
IgG2a (MOPC-173)  0  85 
* Spleen cells of 20-wk-old C57B1/6 and  129/Sv mice were stimulated in vkro for 7 d in the presence of 25 
#g/ml LPS as described  in Materials and Methods.  The medium concentrated sevenfold by precipitation 
with 50% saturated ammonium sulfate  agglutinated 6(I-70% of the IgG1- and lgG2a-cnated particles. 
:~ Inhibitors were heat-aggregated and used at a concentration of 1 mg/rnl. They were preincubated with 
the medium for 2 h at 37°C before addition of the lgG-coa~ed particles. 
§ In percent of control agglutination. 
TABLE  III 
Specificity of Polyclonal Anti-IgG1 Autoantibodies Induced by In  Vitro 
Stimulation with LPS 
Strain* 
Residual:~ anti-IgG1  agglutinating activity after 
absorption with particles  coated with 
IgG1  IgO2a  lgG2b 
(108B7)  (1103G4)  (308A8) 
A/HeJ  10  89  94 
C57BI/6  6  97  97 
CBA/Itt  17  103  115 
RIIIS/J  38  99  97 
129/Sv  16  99  100 
* Media from LPS-stimulated spleen cell cultures were obtained as described 
in Table II. 
~: Media were incubated at room temperature for 2 h with a constant volume 
of particles coated with various IgG preparations.  After centrifugation, the 
residual  agglutinating  activity  towards  IgG1 (108B7)-coated  particles  was 
determined by using a volume of particles  ten times smaller than that used 
for absorption.  This residual  activity was expressed in percent of the control 
agglutination measured after absorption  with particles  coated with an un- 
related protein (mouse transferrin). 
absorption  rather than  competition experiments.  Accordingly, the residual  anti-IgG1 
activity was determined in medium  incubated with a  10-fold excess of particles coated 
with various IgG preparations.  Only IgG 1-coated particles removed anti-IgG 1 activity 
(Table  III).  Similar  results  were  obtained  with  particles  coated  with  two  different 
monoclonal IgG1  preparations  (MOPC-31C  and  108B7). 
Subclass  Specificity  of Monoclonal  RF.  Monoclonal  RF  were  obtained  from  three 
different  sources:  (a)  mice that  spontaneously  produce  RF  in  vivo,  (b)  mice injected 
with LPS, or (c) spleen cells after polyclonal activation in vitro. Clones that  produced 
RF  were  detected  by  screening  culture  media  for  agglutination  of particles  coated 
with  IgG1,  IgG2a,  or IgG2b  in  microtiter plates.  Positive clones were expanded  and 
their  medium  was  retested  for  agglutination  of IgG-coated  particles  by  monitoring VAN  SNICK,  STASSIN,  AND  DE  LESTRE  1011 
the reaction with a particle counter as described (2). The specificity of these reactions 
was checked by testing the ability of heat-aggregated  monoclonal IgG to inhibit the 
agglutination.  Different  Ig of the same  isotype were used  to coat  the  particles  and 
inhibit the reaction so as to restrict this analysis to antibodies specific for constant IgG 
regions. Clones yielding agglutinations that could not be inhibited by heat-aggregated 
IgG  were  found  to  produce  IgM  molecules  that  bound  readily  to  plastic  surfaces 
whatever their protein coat. These clones were discarded.  The specificity  of positive 
clones was further checked by solid-phase radioimmunoassay using flexible polyvinyl 
plates coated with different  IgG preparations.  Typical  specificity  data are shown in 
Fig.  3 and Table IV. 
MONOCLONAL  RF  OBTAINED  WITHOUT  POLYCLONAL  ACTIVATION.  Seven  hybridiza- 
tions were  performed  with  spleen  cells  of adult  129/Sv  mice  (=12  wk old).  They 
yielded a total of =3,000 clones, 26 of which specifically reacted with autologous IgG. 
Of these  26  anti-IgG  clones,  25  were specific  for IgG2a  and  1  for  IgGl.  A  similar 
hybridization carried out with BALB/c  mice produced two anti-IgG2a clones out of 
550 hybridomas. 
MONOCLONAL  RF  OBTAINED  AFTER  POLYCLONAL  ACTIVATION  IN  VIVO.  We  have 
previously shown that, after intraperitoneal  injection of LPS  into 20-wk-old  129/Sv 
mice, it is possible to obtain, at a high frequency, hybridomas with RF activity most 
of which  are  specific  for IgG1.  Here  we  repeated  these  experiments  with  4-wk-old 
129/Sv mice and with 4- or 20-wk-old C57B1/6 mice. Of =3,000 clones, 56 were found 
to  react  with  IgG.  No  significant  difference  in  the  frequency  of these  clones  was 
detected whatever the strain or age of the animals.  11  of these clones were subcloned 
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RELATIVE  ANTI~IgG  CONCENTRATION 
Fl~.  3.  Agglutination oflgG-coated polystyrene particles by monoclonal RF, Culture media from 
various hybridomas were incubated for 1 h  at  37QC with particles coated with IgG1  (108B7  [Q]), 
IgG2a (1103G4 [O]), or IgG2b  (308A8 [A]). The agglutination was measured as described (2). The 
strains of origin  of the  monoclonal  RF  were  as  follows:  C57B1/6  for  A2003B9.1;  BALB/c  for 
A6805F10.1, A8603A11, and A8305H6; CBA/Ht for A5501C5; and 129/Sv for A5701A4, A5701B4, 
A6506G5,  A4403A3, A4403H6, A4401F8,  and H8817D7.6.  Relative anti-IgG concentrations refer 
to dilutions of the RF-containing culture media. 1012  SPECIFICITY  OF  MOUSE  RItEUMATOID  FACTORS 
TABLE  IV 
Subclass-speczficity of Monoclonal RF 
Specificity 
Monoctonal RF 
Origin~  Clone 
Binding* to wells coated with 
lgG3 
IgGl§  IgG2a  IgG2b  (FLOPC 
(108B7)  (1103G4)  (308A8)  -21) 
Anti-IgG1  B6, LPS in vivo 
129/Sv, spontaneous 
129/Sv, LPS +  DS in vitro 
BALB/c, LPS +  DS in vitro 
CBA/Ht, LPS in vitro 
A2003tlll  32  0,9  (1.4  1.9 
tt6314G12  41  1.3  0.5  1.9 
A6505C6  10  0  0  0.1 
A5701A4  46  0.1  0  0.2 
A5703FI2  48  0.1  0.9  0.7 
A6805F10  38  0  3.7  0.5 
A6803F6  16  0  0.6  0.3 
A5501C5  33  0  0.9  0.2 
A9804F4  30  0  0.6  0.2 
Anti-IgG2a  129/Sv spontaneous 
129/Sv, LPS +  DS in vitro 
BALB/c, spontaneous 
BALB/c, LPS +  DS in vitro 
A2901D2  0.6  29  0.3  0.6 
A6107C6  0.2  31  0.2  2.7 
A6501A3  0.4  35  2.3  4.7 
A6608F9  0.9  40  4.5  1.1 
A5701B4  0.8  42  0  1.2 
A5705A5  2.8  26  4.2  1.6 
A8305B4  0.1  14  0  0 
A8601 A2  1  27  0  1.6 
A8602B4  1.2  28  0  1.4 
Anti-lgG2b  129/Sv, LPS +  DS in vitro  A4401 F8  0.6  0.3  37  0.3 
A4403H6  0.5  0  31  0.4 
A4403A3  0.2  0  38  0.2 
* Measured as described in Materials and Methods. Figures represent the mean of triplicate measurements 
expressed in cpm ×  10  -3 after subtraction of the radioactivity bound to wells coated with BSA. 
:~ See explanations in the text. 
§ To remove any contaminating IgM  molecules, IgG preparations were uhracentrifuged over a  sucrose 
gradient. Only the 7S fractions were used to coat the wells. 
and  used for specificity studies.  10 were  specific for IgG1,  and  1 reacted  equally well 
with IgG1  and  IgG2a  (H8817D7.6)  (Fig.  3). 
MONOCLONAL  RF  OBTAINED  AFTER  POLYCLONAL  ACTIVATION  IN  VITRO,  It  is  rela- 
tively difficult  to control  the degree  of polyclonal  activation  obtained  after injection 
of LPS  in FIFO.  Potential  limitations to the activation stem  from  the toxicity of LPS, 
which  varies  from  one  strain  to  another,  and  from  regulatory  influences  of  T 
lymphocytes  (1 1).  Because  in vitro polyclonal  activation overcomes these difficulties, 
spleen  cells of 4-wk-old  mice were  activated  in  vitro with  LPS  or with  a  mixture  of 
LPS  and  DS, which has been reported  to activate 80% of B  lymphocytes  in vitro (12). 
3 d  later the cells were fused with the SP2/0-Ag-14  myeloma  cell line and the resulting 
hybridomas  were  tested  for anti-IgG  activity.  Three  hybridizations  were  carried  out 
with  CBA/Ht  and  129/Sv  mice  and  two  with  BALB/c  mice.  The  total  number  of 
clones  generated  varied  considerably  from  one  experiment  to  another.  In  some,  the 
fusion  frequency  was  so  high  that  it  became  difficult  to  accurately  determine  the 
number  of clones  obtained.  The  latter could  therefore  only be roughly  estimated  at 
=9,000 clones.  34 had  strong anti-IgG activity; of these,  16 were derived from  129/Sv VAN SNICK, STASSIN, AND DE  LESTRE  1013 
spleen cells, 8  with  anti-IgG1 specificity, 4  with  anti-IgG2a specificity, and 4  with 
anti-IgG2b specificity. Six anti-IgG clones were derived from CBA/Ht cells; of these, 
five were anti-IgG1 and one reacted with both IgG2a and IgG2b. Of the 12 BALB/c 
anti-IgG clones, 3 were anti-IgG1 and 9 anti-IgG2a. Like the anti-IgG clones activated 
in vivo either spontaneously or after  injection of LPS,  the  monoclonal RF derived 
from spleen cells polyclonally activated in vitro thus also show a  preferential if not 
exclusive reactivity towards IgG subclass-specific structures. 
Allotypic Specificity  of Monoclonal RF.  We have previously reported  that  the  anti- 
IgG2a RF spontaneously produced by certain mouse strains has an allotypic specificity 
in the  sense that  it  does  not  react  with  IgG2a of the  b  allotype  (3).  The allotypic 
specificity of the monoclonal anti-IgG2a RF obtained here was tested by measuring 
the ability of heat-aggregated IgG2a molecules of the a  and b allotypes to inhibit the 
agglutination of IgG2aa-coated particles. Of the  26 anti-IgG2a clones derived from 
129/Sv spleen ceils without prior polyclonal activation, 6  reacted  indistinctly with 
IgG2a of both allotypes, but 20 failed to react with IgG2a of the b  allotype. The two 
anti-IgG2a clones derived from BALB/c mice under similar conditions showed  the 
same  allotypic specificity. After  polyclonal activation in  vitro, both  kinds of anti- 
IgG2a clones were detected (Table V). No allotypic specificity was detected for anti- 
TABLE  V 
Allotypic Specificity of Anti-IgG2a Autoantibodies 
Origin  Clone 
Inhibition by heat-aggregated~: 
Control*  IgG2a"  IgG2a  b 
aggluti- 
nation 
MOPC-  A6202F4  A7708F11  Poly- 
173§  clonal 
129/Sv, spontaneous 
BALB/c, spontaneous 
BALB/c, LPS 4- DS in vitro 
129/Sv, LPS in vitro 
A2901D2  90  91  91  7  0 
A6107C6  85  100  98  0  0 
A6506G5  56  100  100  9  0 
A6608D6  81  100  100  0  0 
A7105D4  69  100  100  0  0 
A7601E5  74  100  100  0  0 
A6501A3  85  100  100  100  78 
A6504C12  67  100  100  100  85 
A6507A10  89  100  96  96  81 
A8305H6  85  88  90  28  8 
A8603A  11  72  86  100  0  0 
A8607C 1  86  86  65  0  0 
A5701B4  91  100  100  100  90 
A5705A5  77  95  100  95  87 
A5705B8  84  100  100  100  I00 
* Agglutination of particles coated with 1103G4 (IgG2a" of 129/Sv origin). 
Measured as  described in  Materials  and  Methods and  expressed in  percent inhibition  of control 
agglutination. 
§ The polyclonal IgG2a  b was purified from the serum of SJL/J mice. MOPC-173, A6202F4, and A7708FI 1 
are monoclonal IgG2a proteins of BALB/c, 129/Sv, and C57B1/6 origin, respectively.  All four prepara- 
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IgG1  RF, which reacted equally well with polyclonal IgG1 of the b  (C57B1/6)  and d 
(AKR)  allotypes  (13)  and with IgG1 of the a  allotype (data not shown). 
Binding  of Monoclonal RF to Antigen-Antibody  Complexes.  The  hybridomas obtained 
after in vitro polyclonal activation were not only tested for anti-IgG activity but also 
for possible reactivity with  mouse IgM, human  IgG, ovalbumin, and hen egg white 
lysozyme. Although some 40 clones reactive with mouse IgG were obtained in these 
experiments,  no  hybridoma  was  found  to  react  specifically  with  the  other  tested 
proteins. 
In view of this high relative frequency it was important to examine the possibility 
that the anti-IgG antibodies were directed against artefactual antigenic determinants 
that  could result from the adsorption of IgG onto the plastic solid phase used in the 
detection and specificity analyses described above. We therefore tested the reactivity 
of some anti-IgG1 and anti-IgG2a clones with IgG immobilized in a  more physiolog- 
ical way.  The  RF were  mixed with  monoclonal IgG1  and  IgG2a anti-dinitrophenyl 
(DNP) rnonoclonal antibodies in the presence of trinitrophenylated sheep erythrocytes 
(SRBC).  Strong binding of the RF was  observed only when the SRBC  were coated 
with IgG of the appropriate isotype. No binding was observed when IgG 1 and IgG2a 
without anti-DNP activity were used  (Table VI). 
Differential Reactivity of Monoclonal RF with Aggregated and 7S IgG.  Circulating RF in 
both  man  and  mouse  characteristically  have  a  low  affinity  for  IgG.  This  is  well 
illustrated by the fact  that  the agglutination of IgG-coated particles by RF is easily 
inhibited by heat-aggregated  IgG but  very  little by  7S  IgG.  In patients  with  rheu- 
matoid arthritis,  it has been reported  that  high affinity RF is actually produced  but 
is not detectable in the serum  (15). 
TABLE VI 
Binding of Monoclonal Anti-IgG Autoantibodies to Antigen-Antibody Complexes* 
Monoclonal IgM  IgM bound to TNP-SRBC in the presence of:~ 
IgG2a anti-  Clone  Specificity§  IgG1 anti-  IgG1  IgG2a 
DNP  DNP 
8815B511  Anti-IgG1  22  1  3  1 
A5706D9  Anti-IgO  1  23  l  2  i 
A6005B9  Ant  i-IgG2a  I  i  33  I 
A6501 A3  Anti-IgG2a  1  1  43  i 
A5701B4  Anti-lgG2a  1  1  8  1 
8817D711  Anti-(IgG  1 + IgG2a)  33  l  27  1 
101B 11H  Unknown  1  1  2  1 
* SRBC were trinitrophenylated as described  in (14). Equal volumes (25 El) of a  10% cell suspension, of 
monoclonal IgG1 or IgG2a solutions  (100 gg/m[), and of appropriately diluted medium containing 
monoclonal RF were mixed and incubated at  room  temperature for 2 h.  All dilutions were in Tris- 
buffered saline, pH 7.4, containing 5% FBS. After washing, the cell pellet was resuspended  in the same 
diluent containing affinity-purified  goat  anti-mouse IgM  antibodies labeled with  1~I. After  further 
incubation at room  temperature for 2 h  and extensive washing,  the radioactivity associated  with the 
pellet was measured. The figures correspond to specifically bound cpm x  10 3 (obtained after subtraction 
of cpm bound to SRBC incubated with the monoclonal IgM in the absence of any IgG). All tests were 
performed in triplicate. 
:~ The following hybridomas of 129/Sv origin were used:  A6204G12, IgG1 anti-DNP; A6202F4, IgG2a 
anti-DNP; 108B7, IgG1;  1103G4, IgG2a. The last two proteins have no known specificity. 
§ As determined by latex agglutination and solid phase radioimmunoassays. 
I] These  monoclonal IgM proteins  were used in a purified  form at a concentration of 10 #g/ml in Tris- 
buffered saline containing 5% FBS. VAN  SNICK,  STASSIN,  AND  DE  LESTRE  1015 
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F]o.  4.  Inhibition of the agglutination oflgGl-coated particles in the presence of antigen-antibody 
complexes. Antigen-antibody complexes were made  by mixing 400/.tg of a  purified monoclonal 
IgG1  anti-DNP  antibody  (A6204G12)  with  20/tg  of BSA DNPI0.  Complexed  (C)) and  free  (0) 
A6204G12  (25 #1) were incubated with an equal volume of a  monoclonal IgGl-specific IgM RF of 
129/Sv origin (AS007A3).  After 1 h at 37°C, 25 ~l of a  1% suspension of IgGl-coated particles were 
added and the agglutination measured after 1 h more at 37°C. The control agglutination, measured 
in the absence of IgGl, was 80%. 
TABLE  VII 
Reactivity of Monoclonal RF with Aggregated  and 7S IgG 
Monoclonal RF 
Specificity 
Inhibition* of the agglutina- 
tion of lgG-coated particles 
in the presence of 
Aggregated 
Clone  IgG  7S IgG~ 
Anti-lgG2a  A2901D2  I00  0 
A6107C6  100  3 
A6501A3  100  5 
A6608F9  77  0 
A5701B4  100  4 
A8305B4  100  0 
Anti-IgG2b  A4401F8  100  77 
A4403A3  100  71 
A4403H6  100  I(30 
A4409G3  100  82 
* For anti-IgG2a  clones, the  particles  were coated  with  1103G4,  a  129/Sv 
IgG2a  monoclonal  protein,  and  the  competing  IgG  was  MoPe-173,  a 
BALB/c IgG2a myeloma protein. For anti-IgG2b clones, the particles were 
coated with 308A8, a  129/Sv IgG2b hybridoma protein, and the competing 
IgG was MOPC-141,  a  BALB/c myeloma protein. The inhibitions, which 
were carried out  as described in  Materials and  Methods, are expressed in 
percent of the control agglutination. Inhibitors were used at  1 mg/ml. 
:~ Obtained by uhracentrifugation over a sucrose gradient. 
Mouse  monoclonal  RF  produced  in  vitro  in  the  absence  of mouse  serum  should 
give access to such high  affinity autoantibodies.  We  therefore compared  the ability of 
a  7S or complexed  IgG1  anti-DNP  monoclonal  antibody  to  inhibit  the agglutination 1016  SPECIFICITY  OF  MOUSE  RttEUMATOID  FACTORS 
of IgGl-coated particles  by anti-IgG1  clones.  All  anti-IgG1  monoclonal  antibodies 
tested were strongly inhibited by the complexed IgG1, but none was affected by the 
IgG1 used in the absence of antigen. Typical data are shown in Fig. 4. Similar results 
were obtained for all anti-IgG2a clones, which reacted well with IgG2a only when the 
latter was aggregated by heating.  In contrast,  with  all  four monoclonal anti-IgG2b 
RF,  similar  inhibitions  were  obtained  with  7S  and  heat-aggregated  IgG2b  (Table 
VII). 
Discussion 
The RF spontaneously produced by normal mouse strains were found to consist of 
two distinct  antibody populations, one specific for [gGt and one specific for IgG2a. 
This  subclass  specificity seemed  very  strict  as  it  was  impossible  by  agglutination- 
inhibition  experiments  to  detect  any  cross-reaction  between  these  two  RF  species. 
Even the NZB and MRL/1 strains, which produce numerous autoantibodies against 
a  large number of self-antigens,  had  RF with  a  similarly strict  subclass specificity. 
However, their serum contained an additional variety of RF that reacted specifically 
with IgG2b. 
Competition and absorption experiments also resolved the RF secreted in vitro by 
polyclonally activated spleen cells into distinct  subpopulations, each specific for one 
IgG subclass.  Within  the sensitivity limits of these experiments, virtually all  mouse 
RF  appeared  to  be  directed  against  subclass-specific  sites  on  mouse  IgG.  This 
conclusion  was corroborated  by the  results  obtained  with  the  monoclonal  RF  that 
were derived from various strains under different conditions:  of the 73 clones tested, 
71  had a strict subclass specificity. 
In  addition  to  their  subclass  specificity,  some  anti-IgG2a  clones  were  allotype- 
specific  in  the  sense  that  they  failed  to  react  with  IgG2a of the  b  allotype.  This 
suggests that  the antigenic  determinants recognized by these RF  are located  in  the 
hinge region or the CH3 domain of the IgG2a heavy chain, where most amino acid 
substitutions  between the a  and b  allotypic forms of mouse IgG2a have been found 
(16,  17). No such allotypic specificities have so far been detected with anti-IgG1 and 
anti-IgG2b clones. This is probably due to the fact that the divergence between y2a 
alleles is much more important than, for example, that between y2b alleles. It actually 
appears  that  the  third  domain  of the  v2a  b  gene  has  diverged  so  much  from  the 
corresponding v2a  a domain  that  "it  may have derived  from elsewhere in  the  heavy 
chain family" (18). 
Subclass  and  allotype specificities do not  seem to be a  peculiarity  of mouse  RF. 
Most rheumatoid arthritis patients produce RF that react with an antigen, called Ga, 
which  is present on IgG1, IgG2, and IgG4 but  not on IgG3 (19),  and a  minority of 
human RF specifically recognize the "y4 non-a" antigen, which is only found on IgG4 
molecules (20).  In addition, many human RF are specific for allotypic structures.  A 
number of Gm markers have even been identified with rheumatoid sera, e.g., Gm(a), 
(x), (bl), and (g)  (21-24). 
Although  such  similarities between the specificities of human  and  mouse RF  are 
intriguing,  little  is  known  about  their  biological  significance.  The  present  results, 
however, show that in the mouse the subclass specificity of RF depends on the stimuli 
responsible for its induction.  After in vitro polyclonal activation with  LPS and DS, 
spleen cells gave rise to a broad spectrum of subclass-specific RF:  16 were specific for VAN SNICK, STASSIN, AND DE  LESTRE  1017 
IgG1,  13  for IgG2a, and 4  for IgG2b. In contrast, of the 28 monoclonal RF derived 
from BALB/c and  129/Sv mice without prior polyclonal activation, 27 were specific 
for IgG2a and  1 for IgG1, which indicates that under certain conditions anti-IgG2a 
clones can be selectively activated in vivo. In  129/Sv mice, this spontaneous produc- 
tion  of IgG2a-specific RF  is  apparently  induced  by an  infectious  agent  primarily 
located in the intestinal tract. Contamination of RF-negative 129/Sv mice by a single 
intragastric injection of intestinal  fluid from RF-positive animals is indeed sufficient 
to  trigger  a  chronic  production  of this  autoantibody  (manuscript  in  preparation). 
However, because the causative infectious agent has not yet been isolated, it is difficult 
to analyze the mechanisms that result  in such selective activation of IgG2a-specific 
RF. It would therefore be interesting to examine whether it is possible to induce the 
production  of RF  in  the  mouse  in  the  course  of immunizations  with  well-defined 
antigens that do not behave like polyclonal activators. 
Immunization of rabbits with protein antigens has been shown to induce significant 
RF levels (25,  26). If similar responses could be obtained in the mouse, a comparison 
between the subclass specificity of these  RF and the isotypic pattern of the specific 
antibodies induced in such experiments might help to solve the still controversial issue 
of the role of autologous IgG in the induction of RF. 
The hybridomas obtained here after polyclonal activation in  vitro were screened 
not only for RF activity but  for binding to mouse IgM, human IgG, hen lysozyme, 
and ovalbumin as well. Although some 40 IgM-producing clones were found to react 
with mouse IgG subclasses, not a single clone displayed any specific activity towards 
the  other  proteins.  This  raised  the  possibility  of artefactual  interactions  between 
mouse IgM and mouse IgG when the latter is adsorbed onto plastic surfaces. However, 
the  narrow  specificity  of all  these  clones  for  individual  IgG subclasses  made  this 
possibility rather unlikely.  In addition,  the ability of antigen-antibody complexes to 
successfully compete with plastic-bound  IgG for the binding of the anti-IgG clones 
indicated  that  the  antigenic  determinants  recognized  in  these  reactions  are  not 
generated by the mere adsorption of IgG on polystyrene or polyvinyl surfaces. 
It has been shown that  the RF present  in the serum of patients with rheumatoid 
arthritis has a  much lower avidity for IgG than the RF directly secreted by the cells, 
as it can be detected with a plaque-forming cell assay (15). It has been assumed that 
this  high  affinity RF precipitates  in  the extravascular space and  never reaches  the 
serum. It was therefore of interest  to test the affinity of the monoclonal RF derived 
from mice, such as the  129/Sv, which spontaneously produce RF in vivo. Of the 25 
anti-IgG2a clones tested, none reacted significantly with monomeric IgG2a, as indi- 
cated by the failure of 7S IgG2a to inhibit the agglutination of IgG2a-coated particles. 
Also,  the  anti-IgG1  clones  obtained  after in  vitro polyclonal  activation  showed  no 
detectable reaction with monomeric IgG 1 whereas complete inhibition  of agglutina- 
tion  was  observed  with  antigen-bound  IgG1.  In  contrast,  a  strong  inhibition  of 
agglutination with monomeric IgG could be obtained for anti-IgG2b clones, indicating 
that higher affinity RF are present in the mouse although they seem to represent only 
a minor fraction of the mouse RF repertoire. 
Summary 
The  specificity  of polyclonal  mouse  rheumatoid  factors  (RF)  was  analyzed  by 
competition experiments with heat-aggregated mouse IgG subclasses. The RF spon- 1018  SPECIFICITY  OF MOUSE  RHEUMATOID FACTORS 
taneously produced by three normal mouse strains  (129/Sv, CBA/Ht, and C57B1/6) 
and  by  two  strains  with  autoimmune  diseases  (MRL/I  and  NZB)  were  found  to 
consist  of distinct  non-cross-reactive  antibody subpopulations  each specific  for one 
IgG subclass. The sera of the normal strains contained IgG I- and IgG2a-specific RF. 
The autoimmune strains produced  an additional  variety of RF that was specific for 
IgG2b. Also, the  RF secreted  by spleen  cells of various  normal strains  after in vitro 
polyclonal activation with lipopolysaccharide could be resolved into distinct subpop- 
ulations specific for IgG1 or IgG2a. 
These  results  were  confirmed  by  the  analysis  of monoclonal  RF  derived  from 
BALB/c, C57B1/6, CBA/Ht, and  129/Sv mice: of 73 hybridomas with  RF activity, 
71  displayed  a  strict  subclass  specificity.  The  subclass  predominantly  recognized 
depended  on  the  origin  of the  spleen  cells  used  to  generate  the  hybridomas.  After 
polyclonal activation in vitro, a broad spectrum of different specificities was obtained 
with  16  RF specific  for IgG1,  13  for IgG2a, and  4  for IgG2b.  In contrast,  27  of 28 
monoclonal  RF  derived  from  129/Sv  and  BALB/c  mice  without  prior  polyclonal 
activation were specific for IgG2a, and of these  75% were allotype specific since they 
failed to react with IgG2a of the b allotype. These results demonstrate the importance 
of subclass specificity in the production of RF in vivo. 
With  the exception of the IgG2b-specific clones, all  these monoclonal RF reacted 
preferentially  with  heat-aggregated  or antigen-bound  IgG. Among the  hybridomas 
generated by the fusion of in vitro polyclonally activated spleen cells of 4-wk-old mice, 
the  frequency of clones with  RF  activity was  at  least  40  times  higher  than  that  of 
clones specific for mouse IgM, human IgG, ovalbumin, and hen lysozyme. 
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